Get the Stockscreener App
2.76
1.47%
0.04
After Hours:
2.79
0.03
+1.09%
Compugen Ltd stock is traded at $2.76, with a volume of 405.03K.
It is up +1.47% in the last 24 hours and up +26.61% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
See More
Previous Close:
$2.72
Open:
$2.75
24h Volume:
405.03K
Relative Volume:
1.08
Market Cap:
$260.97M
Revenue:
$72.76M
Net Income/Loss:
$35.34M
P/E Ratio:
7.4736
EPS:
0.3693
Net Cash Flow:
$-62.91M
1W Performance:
+6.15%
1M Performance:
+26.61%
6M Performance:
+68.29%
1Y Performance:
+119.05%
1-Day Range:
$2.69
$2.79
1-Week Range:
$2.555
$2.84
52-Week Range:
$1.23
$3.235
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.76 | 257.19M | 72.76M | 35.34M | -62.91M | 0.3693 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-07-26 | Initiated | Lake Street | Buy |
| Jan-07-26 | Initiated | H.C. Wainwright | Buy |
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
Compugen sets May 18 earnings release, 8:30 AM ET webcast - Stock Titan
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026 - Yahoo Finance
Compugen’s Stock Run Highlights A One-Time AstraZeneca Deal - Finimize
Insider Selling: Compugen (NASDAQ:CGEN) CEO Sells 5,000 Shares of Stock - MarketBeat
Compugen (CGEN) SVP sells 2,000 shares under 10b5-1 plan - Stock Titan
Compugen (CGEN) CEO exercises options and sells 5,000 Ordinary Shares - Stock Titan
Compugen CEO Anat Cohen-Dayag to transition to executive chair - MSN
Lake Street initiates coverage of Compugen (CGEN) with buy recommendation - MSN
Ophir Eran plans resale of 5,000 shares (Nasdaq: CGEN) - Stock Titan
Affiliate sells and proposes sales at CGEN (NASDAQ: CGEN) — 4,000 shares planned - Stock Titan
What is the outlook for Compugen (CGEN) stock today (Climbs Higher) 2026-04-27Verified Analyst Reports - Newser
Compugen Q1 2025 Earnings Preview - MSN
Compugen (NASDAQ:CGEN) Share Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
CGEN (Compugen Ltd. Ordinary Shares) posts 161% YoY Q4 2025 revenue growth and massive EPS beat over analyst estimates.Earnings Preview - Cổng thông tin điện tử Tỉnh Sơn La
Compugen (CGEN) Stock: Good Entry Point? (+1.24%) 2026-04-20AI Powered Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La
CGEN SEC FilingsCompugen 10-K, 10-Q, 8-K Forms - Stock Titan
CGEN Insider Sells: Levine Zurit Disposes 2,000 Shares April 16, 2026 - Meyka
Compugen (CGEN) CEO exercises options and sells 5,000 shares under 10b5-1 plan - Stock Titan
[Form 4] COMPUGEN LTD Insider Trading Activity - Stock Titan
Compugen (CGEN) SVP sells 3,125 shares under Rule 10b5-1 plan - Stock Titan
Ophir Eran (CGEN) files to sell 5,000 Ordinary shares under option plan - Stock Titan
CGEN (Nasdaq) Rule 144: 2,000-option shares to be sold; prior 26,375 sale - Stock Titan
Compugen (NASDAQ: CGEN) SVP exercises options, sells 3,125 shares under plan - Stock Titan
Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference - MarketBeat
Levine Zurit sells 24,375 CGEN ordinary shares (CGEN) - Stock Titan
Aug Update: Can Compugen Ltd maintain sales growth2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
VIX Spike: Will Compugen Ltd outperform the market in YEARMarket Volume Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Eran Perry Net Worth (2026) - GuruFocus
Michelle Mahler Net Worth (2026) - GuruFocus
Savitzky Kinneret Livnat Net Worth (2026) - GuruFocus
Gilead Halevy Net Worth (2026) - GuruFocus
Insider Selling: Compugen (NASDAQ:CGEN) SVP Sells 5,375 Shares of Stock - MarketBeat
Compugen (CGEN) SVP exercises options and sells 7,875 Ordinary Shares - Stock Titan
Aug Update: Whats the analyst consensus on Compugen LtdWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Compugen management takes virtual Needham healthcare stage April 13 - Stock Titan
What is the long-term potential of Compugen (CGEN) Stock | Price at $2.46, Up 7.42%Price Target - Newser
Compugen Price Target Announced at $6.00/Share by Lake Street - Moomoo
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Str - GuruFocus
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Street | CGEN Stock News - GuruFocus
Compugen (NASDAQ:CGEN) Coverage Initiated by Analysts at Lake Street Capital - MarketBeat
Lake Street Initiates Compugen(CGEN.US) With Buy Rating, Announces Target Price $6 - Moomoo
Compugen (NASDAQ:CGEN) CEO Sells $12,431.25 in Stock - Defense World
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Compugen (CGEN) SVP exercises stock options and sells 3,500 shares under 10b5-1 plan - Stock Titan
Compugen (CGEN) CEO exercises options and sells 5,625 shares in 10b5-1 trade - Stock Titan
Compugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
[144] COMPUGEN LTD SEC Filing - Stock Titan
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Compugen Ltd Stock (CGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Levine Zurit | SVP, Business Development |
Apr 24 '26 |
Sale |
3.20 |
2,000 |
6,400 |
29,375 |
| Ophir Eran | President and CEO |
Apr 24 '26 |
Option Exercise |
0.83 |
5,000 |
4,146 |
16,375 |
| Ophir Eran | President and CEO |
Apr 24 '26 |
Sale |
3.20 |
5,000 |
16,000 |
11,375 |
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):